Published in Biomedicine on March 01, 1975
Epidemiologic investigation of immune-mediated polyradiculoneuropathy among abattoir workers exposed to porcine brain. PLoS One (2010) 0.95
Cytokine control of inflammation and repair in the pathology of multiple sclerosis. Yale J Biol Med (2012) 0.92
Complexity of trophic factor signaling in experimental autoimmune encephalomyelitis: differential expression of neurotrophic and gliotrophic factors. J Neuroimmunol (2013) 0.80
A mushroom extract Piwep from Phellinus igniarius ameliorates experimental autoimmune encephalomyelitis by inhibiting immune cell infiltration in the spinal cord. Biomed Res Int (2014) 0.77
Myelin ultrastructure of sciatic nerve in rat experimental autoimmune neuritis model and its correlation with associated protein expression. Int J Clin Exp Pathol (2015) 0.75
The postviral fatigue syndrome--an analysis of the findings in 50 cases. J Infect (1985) 4.39
Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. BMJ (1991) 3.65
Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture. Nature (1978) 3.29
Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. BMJ (1992) 2.64
Myalgic encephalomyelitis--report of an epidemic. J R Coll Gen Pract (1983) 2.64
Postviral fatigue syndrome: persistence of enterovirus RNA in muscle and elevated creatine kinase. J R Soc Med (1988) 2.60
Epidemic myalgic encephalomyelitis. Practitioner (1980) 2.53
Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy. Lancet (1976) 2.31
The symptoms of chronic fatigue syndrome are related to abnormal ion channel function. Med Hypotheses (2000) 2.10
Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies. Ann Neurol (1977) 1.84
Fatigue and basal ganglia. J Neurol Sci (2000) 1.82
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group. Neurology (1999) 1.82
Antiviral pathway activation in patients with chronic fatigue syndrome and acute infection. Clin Infect Dis (2001) 1.72
Antibody to Coxsackie B virus in diagnosing postviral fatigue syndrome. BMJ (1991) 1.69
Muscular dystrophy in young girls. Neurology (1970) 1.60
'Onion bulb' formations in the central and peripheral nervous system in association with multiple sclerosis and hypertrophic polyneuropathy. Brain (1977) 1.56
Myasthenic crisis. QJM (2008) 1.52
The thymus in myasthenia gravis. Evidence for altered cell populations. N Engl J Med (1974) 1.50
Cell type-specific markers for human glial and neuronal cells in culture. Lab Invest (1980) 1.49
Serum folate and chronic fatigue syndrome. Neurology (1993) 1.47
Gangliosides and neurological diseases. BMJ (1992) 1.43
A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis. Eur J Neurol (2001) 1.41
Acute cervical hyperextension-hyperflexion injury may precipitate and/or exacerbate symptomatic multiple sclerosis. Eur J Neurol (2001) 1.37
Cell-mediated immunity to myelin basic protein in acute disseminated encephalomyelitis. Neurology (1974) 1.35
Experimental allergic neuritis induced by sensitization with galactocerebroside. Science (1979) 1.26
Paraneoplastic limbic encephalitis: clinico-pathological correlations. J Neurol Neurosurg Psychiatry (1990) 1.26
Multiple sclerosis and Sjögren's syndrome: a problem in diagnosis or in definition of two disorders of unknown etiology? Ann Neurol (1990) 1.26
Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group. Mult Scler (2000) 1.23
Isolation of myelin basic protein-reactive T-cell lines from normal human blood. Cell Immunol (1983) 1.23
Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol (1991) 1.22
Landry-Guillain-Barré-Strohl syndrome and immune-complex nephritis. Lancet (1973) 1.22
Neurological dysfunction in two patients receiving captopril and cimetidine. Lancet (1980) 1.20
Antibodies to oligodendroglia in patients with multiple sclerosis. N Engl J Med (1977) 1.20
Limiting dilution analysis of the frequency of antigen-reactive lymphocytes isolated from the central nervous system of Lewis rats with experimental allergic encephalomyelitis. Cell Immunol (1987) 1.20
Dissociation of antibody production from disease suppression in the inhibition of allergic encephalomyelitis by myelin basic protein. J Immunol (1970) 1.19
Immune disease and HLA associations with myasthenia gravis. J Neurol Neurosurg Psychiatry (1980) 1.17
Delayed hypersensitivity to encephalitogenic protein in disseminated encephalomyelitis. Lancet (1968) 1.17
Neurological aspects of mycoplasmal infection. Acta Neurol Scand (1986) 1.16
A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients. Mult Scler (2006) 1.15
Circulating immune complexes in multiple sclerosis and other neurological diseases. Lancet (1976) 1.14
Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci U S A (2001) 1.13
Hyperkalemic periodic paralysis and cardiac arrhythmia. Neurology (1972) 1.13
Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome. Clin Exp Immunol (1991) 1.11
T and B lymphocytes in multiple sclerosis. Clin Exp Immunol (1975) 1.09
Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis. J Immunol (1981) 1.09
In vitro cell-mediated immunity of cerebrospinal-fluid lymphocytes to myelin basic protein in primary demyelinating diseases. N Engl J Med (1977) 1.09
Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients. Isr J Med Sci (1978) 1.09
Palatal myoclonus successfully treated with clonazepam. J Neurol Neurosurg Psychiatry (1990) 1.07
Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders. Ann Neurol (1980) 1.07
Immune responses to myelin basic protein in mycobacterial-induced suppression of experimental allergic encephalomyelitis. Cell Immunol (1974) 1.06
Studies on the nature of autoimmunity in myasthenia gravis. Evidence for an immunodeficiency type. Ann N Y Acad Sci (1976) 1.04
Transient global amnesia due to a dominant hemisphere tumor. Arch Neurol (1977) 1.03
Allergic encephalomyelitis: effect of complement depletion with cobra venom. Proc Soc Exp Biol Med (1971) 1.02
In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome. Ann Neurol (1982) 1.02
Letter: Immune response genes in myasthenia gravis. Lancet (1973) 1.02
Mitogens for glial cells: a comparison of the response of cultured astrocytes, oligodendrocytes and Schwann cells. Brain Res (1981) 1.02
Immunologic mechanisms in experimental encephalomyelitis in nonhuman primates. Arch Neurol (1973) 1.00
In vivo magnetic resonance spectroscopy in chronic fatigue syndrome. Prostaglandins Leukot Essent Fatty Acids (2004) 0.99
Azathioprine in the treatment of myasthenia gravis. Ann Neurol (1984) 0.99
Guillain-Barré syndrome (GBS) with bilateral optic neuritis and central white matter disease. Neurology (1993) 0.99
Antimyelin antibodies in neurologic diseases. Immunofluorescent demonstration. Arch Neurol (1975) 0.98
Search for anti-encephalitogen antibody in human demyelinative diseases. Neurology (1968) 0.98
Letter: Impaired cell-mediated immunity in human brain tumours. Lancet (1975) 0.98
Multiple sclerosis: evidence for immunopathogenesis. Neurology (1980) 0.98
Search for retrovirus in the chronic fatigue syndrome. J Clin Pathol (1992) 0.97
Long term culture of bovine oligodendroglia isolated with a Percoll gradient. Brain Res (1981) 0.97
GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient. J Autoimmun (1999) 0.96
Letter: Rosette tests following thymectomy. Lancet (1975) 0.96
Immunopathogenesis and treatment of myasthenia gravis. J Clin Immunol (1987) 0.96
Immunologic characterization of cerebrospinal fluid lymphocytes: preliminary report. Neurology (1976) 0.96
The isolation and long-term culture of oligodendrocytes from newborn mouse brain. Brain Res (1984) 0.96
Neurologic consequence of delaying glatiramer acetate therapy for multiple sclerosis: 8-year data. Acta Neurol Scand (2005) 0.96
Antigalactocerebroside serum demyelinates optic nerve in vivo. J Neurol Sci (1984) 0.96
A correlation between severity of migraine and delayed gastric emptying measured by an epigastric impedance method. Br J Clin Pharmacol (1990) 0.95
Late onset of Guillain-Barré syndrome. J Neuroimmunol (1982) 0.95
Plasma-exchange combined with immunosuppressive therapy in myasthenia gravis. Lancet (1979) 0.95
HLA-B8 in polymyositis. N Engl J Med (1978) 0.95
Aspects of lymphocyte function in myasthenia gravis. Ann N Y Acad Sci (1976) 0.95
Nifedipine in the treatment of myotonia in myotonic dystrophy. J Neurol Neurosurg Psychiatry (1987) 0.95
Cranial computed tomography in the diagnosis of systemic lupus erythematosus. Ann Neurol (1979) 0.93
The role of viral infection in polymyositis, dermatomyositis and chronic fatigue syndrome. Baillieres Clin Neurol (1993) 0.93
A search for antibodies against glial cells in the serum and cerebrospinal fluid of patients with multiple sclerosis and Guillain-Barré syndrome. J Neurol Sci (1979) 0.93
Cell-mediated hypersensitivity to neural antigens. Occurrence in human patients and nonhuman primates with neurological diseases. Arch Neurol (1972) 0.93
A case of progressive encephalomyelitis with rigidity and positive antiglutamic acid decarboxylase antibodies [corrected]. J Neurol Neurosurg Psychiatry (1991) 0.93
Immunological features of polymyositis/dermatomyositis. Springer Semin Immunopathol (1985) 0.92
Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus. Ann N Y Acad Sci (2002) 0.91
Hyperacute experimental allergic neuritis. Res Commun Chem Pathol Pharmacol (1971) 0.91
In vitro and in vivo immune responses to homologous myelin basic protein in experimental allergic encephalomyelitis. Cell Immunol (1974) 0.91
Immunopathological mechanisms of allergic neuritis in animals, primates, and man. Trans Am Neurol Assoc (1969) 0.91
Mycobacterial suppression of delayed hypersensitivity in experimental allergic encephalomyelitis. Proc Soc Exp Biol Med (1968) 0.91
The ophthalmoplegic form of the Guillain-Barre-syndrome: an immunologic study. Acta Ophthalmol (Copenh) (1973) 0.91
Long-term culture of oligodendrocytes isolated from rat corpus callosum by Percoll density gradient. Lysis by polyclonal antigalactocerebroside serum. J Neuropathol Exp Neurol (1983) 0.90
Recurrent acute necrotizing hemorrhagic incephalopathy. Acta Neuropathol (1972) 0.90
Serological techniques for detection of antibody to galactocerebroside. J Immunol Methods (1976) 0.90
Myasthenia gravis: immunological mechanisms and immunotherapy. Ann Neurol (1995) 0.89